1. Home
  2. PBYI vs SHMD Comparison

PBYI vs SHMD Comparison

Compare PBYI & SHMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBYI
  • SHMD
  • Stock Information
  • Founded
  • PBYI 2010
  • SHMD 1864
  • Country
  • PBYI United States
  • SHMD Germany
  • Employees
  • PBYI N/A
  • SHMD N/A
  • Industry
  • PBYI Biotechnology: Pharmaceutical Preparations
  • SHMD
  • Sector
  • PBYI Health Care
  • SHMD
  • Exchange
  • PBYI Nasdaq
  • SHMD Nasdaq
  • Market Cap
  • PBYI 126.5M
  • SHMD 144.7M
  • IPO Year
  • PBYI N/A
  • SHMD N/A
  • Fundamental
  • Price
  • PBYI $2.42
  • SHMD $2.64
  • Analyst Decision
  • PBYI Strong Buy
  • SHMD
  • Analyst Count
  • PBYI 1
  • SHMD 0
  • Target Price
  • PBYI $7.00
  • SHMD N/A
  • AVG Volume (30 Days)
  • PBYI 524.8K
  • SHMD 25.6K
  • Earning Date
  • PBYI 11-07-2024
  • SHMD 11-26-2024
  • Dividend Yield
  • PBYI N/A
  • SHMD N/A
  • EPS Growth
  • PBYI 492.79
  • SHMD 1309.32
  • EPS
  • PBYI 0.47
  • SHMD 1.07
  • Revenue
  • PBYI $243,569,000.00
  • SHMD $99,752,404.00
  • Revenue This Year
  • PBYI N/A
  • SHMD N/A
  • Revenue Next Year
  • PBYI N/A
  • SHMD N/A
  • P/E Ratio
  • PBYI $5.20
  • SHMD $2.60
  • Revenue Growth
  • PBYI 6.30
  • SHMD N/A
  • 52 Week Low
  • PBYI $2.23
  • SHMD $2.38
  • 52 Week High
  • PBYI $7.73
  • SHMD $6.13
  • Technical
  • Relative Strength Index (RSI)
  • PBYI 36.08
  • SHMD N/A
  • Support Level
  • PBYI $2.83
  • SHMD N/A
  • Resistance Level
  • PBYI $3.25
  • SHMD N/A
  • Average True Range (ATR)
  • PBYI 0.29
  • SHMD 0.00
  • MACD
  • PBYI -0.04
  • SHMD 0.00
  • Stochastic Oscillator
  • PBYI 6.03
  • SHMD 0.00

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

About SHMD SCHMID Group N.V. Class A Ordinary Shares

Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).

Share on Social Networks: